Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: A report of Radiation Therapy Oncology Group 83-02

Journal of Clinical Oncology

Volumn 11, Issue 5, 1993, Pages 857-862

  Curran Jr , W J ^a   Scott, C B ^a   Weinstein, A S ^a   Martin, L A ^a   Nelson, J S ^a   Phillips, T L ^a   Murray, K ^a   Fischbach, A J ^a   Yakar, D ^a   Schwade, J G ^a   Corn, B ^a   Nelson, D F ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PERFORMANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSURGERY; RANDOMIZATION; STEREOTAXIC SURGERY;

EID: 0027230540     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1993.11.5.857     Document Type: Article

References (0)